Cellectis SA (CLLS)
4.28
+0.69
(+19.22%)
USD |
NASDAQ |
Apr 13, 16:00
4.27
-0.01
(-0.23%)
After-Hours: 20:00
Cellectis Cash from Investing (TTM) : -29.58M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| DBV Technologies SA | -1.373M |
| EDAP TMS SA | -5.726M |
| Sanofi | -2.854B |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -0.9012M |